8d
Hosted on MSNMerck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?Key Takeaways Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck ...
Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target ...
Heatwave vs nonheatwave days were associated with an increased risk for emergency department visits and hospital admissions due to infectious diseases and infectious enteritis and heat-related ...
Merck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the U.S. Food and Drug Administration's website. Zinplava, first approved by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results